Drugs / Qifangfeixian granules
Qifangfeixian granules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06674148 | Oct 2024 → May 2027 expected | interstitial lung disease | Huilan Zhang | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Qifangfeixian granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06674148 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Qifangfeixian granule is derived from "Fangji Huangqi Decoction" in the Summary of Golden Chamber.” NCT06674148 ↗ |